Cheryl Pirozzi,
MD
Languages Spoken: English, Spanish
Specialties
Board Certification and Academic Information
| Academic Departments | Internal Medicine
-
Associate Professor (Clinical) |
| Academic Divisions | Pulmonary |
| Board Certification | American Board of Internal Medicine American Board of Internal Medicine (Sub: Critical Care Medicine) American Board of Internal Medicine (Sub: Pulmonary Disease) |
Patient Rating
The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of recommending care provider
4.9/ 5
Care provider's explanation of condition/problem
4.8/ 5
Care provider's effort to include me in decisions
4.8/ 5
Wait time at clinic
4.6/ 5
Care provider's concern for questions & worries
4.9/ 5
Patient Comments
Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
UofU Patient
November 20, 2022
University Hospital
Dr. Pirozzi listens to my concerns & questions. She is also willing to coordinate with my allergist to keep my asthma symptoms at bay. I am so fortunate to have her as my pulmonologist.
UofU Patient
November 13, 2022
University Hospital
Very thorough, follow through on things
UofU Patient
October 28, 2022
University Hospital
The U is a wonderful place, we are lucky
UofU Patient
October 21, 2022
UH HOSPITALS AND CLINICS
Love Dr Pirozzi and her team.
UofU Patient
October 19, 2022
UH HOSPITALS AND CLINICS
Very good
UofU Patient
September 09, 2022
UH HOSPITALS AND CLINICS
I'm very impressed with Dr. Pirrozi. She took her time (this was my first regular appointment w/ her), she asked thoughtful questions, and she identified what I thought were the critical issues. Ordered some exams to eliminate some possibilities and got immediately back to me when she got results. Couldn't ask for more.
UofU Patient
July 28, 2022
UH HOSPITALS AND CLINICS
Good
UofU Patient
April 16, 2022
UH HOSPITALS AND CLINICS
Dr Purrozi is a very efficient specialist as well as very concerned about my respiratory health.
UofU Patient
February 22, 2022
UH HOSPITALS AND CLINICS
Very good
UofU Patient
February 04, 2022
UH HOSPITALS AND CLINICS
Dr.Pirozzi is great! We review everything and plot going forward. Professional, succinct and talks clearly
UofU Patient
December 03, 2021
UH HOSPITALS AND CLINICS
Excellent care.
UofU Patient
November 07, 2021
UH HOSPITALS AND CLINICS
Dr. Pirozzi also gave us information for any of our children who might have my inherited health problem so they can be tested. Thank you.
UofU Patient
November 07, 2021
UH HOSPITALS AND CLINICS
My experience is that physicians generally do not explain diagnosis and treatment as well as midlevel practitioners do, and Dr Pirozzi is no exception. I find her to be an excellent physicianand kind and patient person. She tolerates my prying information out of her very well!
UofU Patient
October 24, 2021
UH HOSPITALS AND CLINICS
Dr. Pirozzi is always amazing. It is apparent that she has familiarized herself with any labs/services I've add prior to my visit. She is engaged and active in my care. If I have issues between visits, she is responsive through MyChart or phone. I always feel confident in her review and the plan of care.
UofU Patient
October 08, 2021
UH HOSPITALS AND CLINICS
Dr. Pirozzi is very caring and knowledgeable.
UofU Patient
September 20, 2021
UH HOSPITALS AND CLINICS
Dr. Pirozzi is always professional
UofU Patient
August 23, 2021
UH HOSPITALS AND CLINICS
Dr. Pirozzi is good natured and confident, which inspires the patient's security and confidence in her work. As a good colleague and professor, she allowed Kaden the internist under her supervision to make a preliminary assessment of my problems. Then during her examination, she made her own diagnosis of my problems. She then delivered the excellent news of my lab tests taken the month before, which proved her success. For nearly a decade, her treatments have helped me rise above my bronchitis and COPD. On her recommendation back in 2013, I took my first breathing test in the pulmonology lab, and I scored low in oxygen transfer. Due to my maladies, my lungs were transferring oxygen at only around 50% of normal into the bloodstream. In my breathing test last month, however, thanks to her prescriptions and care, my oxygen transfer has increased to the 80th percentile of normal. Dr. Pirozzi epitomizes the Hippocratic oath of the medical profession: she will go the extra mile for the good of the patient. For several years I had been dealing with exorbitant pricing of Symbicort, the only inhaler that I can use that does not leave me hoarse. However, after the participation of my Medicare and my Navitus Medicare supplement coverages, my copay for each Symbicort inhaler was $150 and $112 for generic! Dr. Pirozzi worked with the university pharmacy to obtain a grant from the manufacturer Astra-Zeneca. When that fell through, she again went to bat for me at Navitus. After her negotiations, she obtained the price $69 for each generic inhaler-finally a price that I could afford.Dr. Pirozzi merits your superlative rating: whether it be 5 stars or A+++, -she is tops! To be sure, I mention her and the other excellent doctors I have at the University of Utah. I receive there the best healthcare of my entire life. Dr. Cheryl Pirozzi an outstanding exemplar of both the U of U Hospital and Clinics and one of our significant and revered pulmonologists who has saved the planet from respiratory failure, including the Covid pandemic.
UofU Patient
August 22, 2021
UH HOSPITALS AND CLINICS
Every doctor I've met with in Pulmonary has been excellent. Dr. Pirozzi is excellent.
UofU Patient
July 26, 2021
SUGAR HOUSE HEALTH CENTER
Dr. Pirozzi is always prepared for the visit. She reviews tests and current status and upcoming plan in great detail.
UofU Patient
June 12, 2021
UH HOSPITALS AND CLINICS
excellent experience
UofU Patient
June 03, 2021
UH HOSPITALS AND CLINICS
could not ask for better care.
UofU Patient
May 18, 2021
UH HOSPITALS AND CLINICS
Excellent communication.
UofU Patient
May 07, 2021
UH HOSPITALS AND CLINICS
Cheryl is a fantastic doctor. she always takes the time to explain everything which I really appreciate.
UofU Patient
April 24, 2021
UH HOSPITALS AND CLINICS
everything was normal
UofU Patient
March 19, 2021
UH HOSPITALS AND CLINICS
Dr Pirozzi is wonderful
Academic Locations
Board Certification and Academic Information
| Academic Departments | Internal Medicine
-
Associate Professor (Clinical) |
| Academic Divisions | Pulmonary |
| Board Certification | American Board of Internal Medicine American Board of Internal Medicine (Sub: Critical Care Medicine) American Board of Internal Medicine (Sub: Pulmonary Disease) |
Education History
| Graduate Training | University of Utah Master of Science in Clinical Investigation M.S., 2015 |
| Fellowship | University of Utah Pulmonary and Critical Care Medicine Fellow, 2013 |
| Chief Resident | University of Utah Internal Medicine Chief Medical Resident, 2010 |
| Residency | University of Utah Internal Medicine Resident, 2009 |
| Professional Medical | Brown University School of Medicine Medicine, International medicine elective in the Dominican Republic M.D., 2006 |
| Undergraduate | Dartmouth Medical School The Dartmouth-Brown Program, Ohiyesa Medical Spanish Language Program, Antigua, Guatemala , 2004 |
| Undergraduate | Dartmouth College Biology, Minor in Studio Art B.A., 2000 |
Selected Publications - Journal Articles
Journal Article
- Ronish BE, Couper DJ, Barjaktarevic IZ, Cooper CB, Kanner RE, Pirozzi CS, Kim V, Wells JM, Han MK, Woodruff PG, Ortega VE, Peters SP, Hoffman EA, Buhr RG, Dolezal BA, Tashkin DP, Liou TG, Bateman LA, Schroeder JD, Martinez FJ, Barr RG, Hansel NN, Comellas AP, Rennard SI, Arjomandi M, Paine Iii R (2022). Forced Expiratory Flow at 25%-75% Links COPD Physiology to Emphysema and Disease Severity in the SPIROMICS Cohort. Chronic Obstr Pulm Dis, 9(2), 111-121.
- Belz DC, Woo H, Putcha N, Paulin LM, Koehler K, Fawzy A, Alexis NE, Barr RG, Comellas AP, Cooper CB, Couper D, Dransfield M, Gassett AJ, Han M, Hoffman EA, Kanner RE, Krishnan JA, Martinez FJ, Paine R 3rd, Peng RD, Peters S, Pirozzi CS, Woodruff PG, Kaufman JD, Hansel NN, SPIROMICS Investigators (2022). Ambient ozone effects on respiratory outcomes among smokers modified by neighborhood poverty: An analysis of SPIROMICS AIR. Sci Total Environ, 829, 154694.
- Johnson SA, Mendoza DL, Zhang Y, Pirozzi CS (2021). Effects of Short-Term Air Pollution Exposure on Venous Thromboembolism: A Case-Crossover Study. Ann Am Thorac Soc, 18(12), 1988-1996.
- Aberegg SK, Cirulis MM, Maddock SD, Freeman A, Keenan LM, Pirozzi CS, Raman SM, Schroeder J, Mann H, Callahan SJ (2020). Clinical, Bronchoscopic, and Imaging Findings of e-Cigarette, or Vaping, Product Use-Associated Lung Injury Among Patients Treated at an Academic Medical Center. JAMA Netw Open, 3(11), e2019176.
- Ortega VE, Li X, ONeal WK, Lackey L, Ampleford E, Hawkins GA, Grayeski PJ, Laederach A, Barjaktarevic I, Barr RG, Cooper C, Couper D, Han MK, Kanner RE, Kleerup EC, Martinez FJ, Paine Iii R, Peters SPPirozzi C, Rennard SI, Woodruff PG, Hoffman EA, Meyers DA, Bleecker ER NHLBI Subpopulations and Intermediate Outcomes Measures in COPD Study SPIROMICS (2020). The Effects of Rare SERPINA1 Variants on Lung Function and Emphysema in SPIROMICS. Am J Respir Crit Care Med, 201(5), 540-554.
- Maddock SD, Cirulis MM, Callahan SJ, Keenan LM, Pirozzi CS, Raman SM, Aberegg SK (2019). Pulmonary Lipid-Laden Macrophages and Vaping. . N Engl J Med, 381(15), 1488-1489.
- Pirozzi CS, Jones BE, VanDerslice JA, Zhang Y, Paine R 3rd, Dean NC (April 1 2018). Short-Term Air Pollution and Incident Pneumonia: A Case-Crossover Study. Ann Am Thorac Soc, 15(4), 449-459.
- Hansel NN, Paulin LM, Gassett AJ, Peng RD, Alexis N, Fan VS, Bleecker E, Bowler R, Comellas AP, Dransfield M, Han MK, Kim V, Krishnan JA, Pirozzi C, Cooper CB, Martinez F, Woodruff PG, Breysse PJ, Barr RG, Kaufman JD (2017). Design of the Subpopulations and Intermediate Outcome Measures in COPD (SPIROMICS) AIR Study. BMJ Open Respir Res, 4(1), e000186.
- Martinez CH, Diaz AA, Meldrum C, Curtis JL, Cooper CB, Pirozzi C, Kanner RE, Paine R 3rd, Woodruff PG, Bleecker ER, Hansel NN, Barr RG, Marchetti N, Criner GJ, Kazerooni EA, Hoffman EA, Ross BD, Galban CJ, Cigolle CT, Martinez FJ, Han MK, SPIROMICS Investigators (2016). Age and Small Airway Imaging Abnormalities in Subjects with and without Airflow Obstruction in SPIROMICS. Am J Respir Crit Care Med, 195(4), 464-472.
Letter
Other
- Zusman M, Gassett AJ, Kirwa K, Barr RG, Cooper CB, Han MK, Kanner RE, Koehler K, Ortega VE, Paine Rd R, Paulin L, Pirozzi C, Rule A, Hansel NN, Kaufman JD (2020). Modeling residential indoor concentrations of PM2.5 , NO2 , NOx , and secondhand smoke in the Subpopulations and Intermediate Outcome Measures in COPD (SPIROMICS) Air study. Indoor Air (31(3), pp. 702-716). England.
- Burkes RM, Ceppe AS, Doerschuk CM, Couper D, Hoffman EA, Comellas AP, Barr RG, Krishnan JA, Cooper C, Labaki WW, Ortega VE, Wells JM, Criner GJ, Woodruff PG, Bowler RP, Pirozzi CS, Hansel NN, Wise RA, Brown TT, Drummond MB, SPIROMICS Investigators (2020). Associations Among 25-Hydroxyvitamin D Levels, Lung Function, and Exacerbation Outcomes in COPD: An Analysis of the SPIROMICS Cohort. Chest (157(4), pp. 856-865). United States.
- Ortega VE, Li X, ONeal WK, Lackey L, Ampleford E, Hawkins GA, Grayeski PJ, Laederach A, Barjaktarevic I, Barr RG, Cooper C, Couper D, Han MK, Kanner RE, Kleerup EC, Martinez FJ, Paine R 3rd, Peters SP, Pirozzi C, Rennard SI, Woodruff PG, Hoffman EA, Meyers DA, Bleecker ER, NHLBI Subpopulations and Intermediate Outcomes Measures in COPD Study SPIROMICS (2019). The Effects of Rare SERPINA1 Variants on Lung Function and Emphysema in SPIROMICS. Am J Respir Crit Care Med (201(5), pp. 540-554). United States.
- Paulin LM, Gassett AJ, Alexis NE, Kirwa K, Kanner RE, Peters S, Krishnan JA, Paine R 3rd, Dransfield M, Woodruff PG, Cooper CB, Barr RG, Comellas AP, Pirozzi CS, Han M, Hoffman EA, Martinez FJ, Woo H, Peng RD, Fawzy A, Putcha N, Breysse PN, Kaufman JD, Hansel NN, for SPIROMICS investigators (2019). Association of Long-term Ambient Ozone Exposure With Respiratory Morbidity in Smokers. JAMA Intern Med (180(1), pp. 106-115). United States.
- Paulin LM, Smith BM, Koch A, Han M, Hoffman EA, Martinez C, Ejike C, Blanc PD, Rous J, Barr RG, Peters SP, Paine R 3rd, Pirozzi C, Cooper CB, Dransfield MT, Comellas AP, Kanner RE, Drummond MB, Putcha N, Hansel NN (2018). Occupational Exposures and Computed Tomographic Imaging Characteristics in the SPIROMICS Cohort. Ann Am Thorac Soc (15(12), pp. 1411-1419). United States.
- Pirozzi CS, Gu T, Quibrera PM, Carretta EE, Han MK, Murray S, Cooper CB, Tashkin DP, Kleerup EC, Barjaktarevic I, Hoffman EA, Martinez CH, Christenson SA, Hansel NN, Graham Barr R, Bleecker ER, Ortega VE, Martinez FJ, Kanner RE, Paine R 3rd, NHLBI SubPopulations and InteRmediate Outcome Measures In COPD Study SPIROMICS (2018). Heterogeneous burden of lung disease in smokers with borderline airflow obstruction. Respir Res (19(1), p. 223). England.
- Pirozzi CS, Mendoza DL, Xu Y, Zhang Y, Scholand MB, Baughman RP (2018). Short-Term Particulate Air Pollution Exposure is Associated with Increased Severity of Respiratory and Quality of Life Symptoms in Patients with Fibrotic Sarcoidosis. Int J Environ Res Public Health (15(6)). Switzerland.
- Pirozzi CS, Jones BE, VanDerslice JA, Zhang Y, Paine R 3rd, Dean NC (2017). Short-Term Air Pollution and Incident Pneumonia. A Case-Crossover Study. Ann Am Thorac Soc (15(4), pp. 449-459). United States.